ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
SouthernAccent
|
34 |
18K |
16 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
18K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: AIPAC-003 safety lead-in data presented at ESMO Breast 2024
|
|
SouthernAccent
|
16 |
6.7K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
6.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: AIPAC-003 safety lead-in data presented at ESMO Breast 2024
|
|
SouthernAccent
|
16 |
6.7K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
6.7K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
SouthernAccent
|
42 |
16K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
16K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
SouthernAccent
|
42 |
16K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
16K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
SouthernAccent
|
42 |
16K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
16K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
SouthernAccent
|
42 |
16K |
6 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
16K
|
6
|
|
ASX - By Stock
|
IMM |
EFTI at 90
|
|
SouthernAccent
|
42 |
16K |
21 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
16K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
SouthernAccent
|
562 |
250K |
21 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
562
|
250K
|
21
|
|
ASX - By Stock
|
IMM |
Marc do your job!
|
|
SouthernAccent
|
42 |
18K |
11 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
42
|
18K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive Feedback received from Spanish Medicines Agency
|
|
SouthernAccent
|
4 |
2.1K |
10 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4
|
2.1K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
SouthernAccent
|
743 |
332K |
19 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
743
|
332K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
SouthernAccent
|
743 |
332K |
14 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
743
|
332K
|
14
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
SouthernAccent
|
92 |
27K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
92
|
27K
|
7
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
SouthernAccent
|
1.6K |
863K |
0 |
25/01/24 |
25/01/24 |
Charts
|
1.6K
|
863K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
SouthernAccent
|
92 |
30K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
92
|
30K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
SouthernAccent
|
92 |
30K |
2 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
92
|
30K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
SouthernAccent
|
121 |
53K |
26 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
53K
|
26
|
|
ASX - By Stock
|
IMM |
JPM conference.
|
|
SouthernAccent
|
1 |
1.1K |
17 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
1
|
1.1K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
SouthernAccent
|
743 |
332K |
14 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
743
|
332K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
9 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
10K
|
4.6M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
SouthernAccent
|
3 |
2.3K |
9 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
3
|
2.3K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
10K
|
4.6M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
13 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
10K
|
4.6M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
11 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
10K
|
4.6M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
18 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
10K
|
4.6M
|
18
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
SouthernAccent
|
29 |
13K |
1 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
29
|
13K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
SouthernAccent
|
29 |
13K |
7 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
29
|
13K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
SouthernAccent
|
29 |
13K |
15 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
29
|
13K
|
15
|
|
ASX - By Stock
|
NEU |
M&A
|
|
SouthernAccent
|
29 |
13K |
20 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
29
|
13K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
SouthernAccent
|
986 |
498K |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
986
|
498K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
SouthernAccent
|
107 |
62K |
8 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
107
|
62K
|
8
|
|
ASX - By Stock
|
PAB |
ADC's on the move........
|
|
SouthernAccent
|
9 |
2.8K |
8 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
9
|
2.8K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
along for the ride
|
|
SouthernAccent
|
22 |
11K |
3 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
22
|
11K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
SouthernAccent
|
92 |
30K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
92
|
30K
|
1
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
SouthernAccent
|
1.6K |
863K |
3 |
05/11/23 |
05/11/23 |
Charts
|
1.6K
|
863K
|
3
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
SouthernAccent
|
1.6K |
863K |
8 |
05/11/23 |
05/11/23 |
Charts
|
1.6K
|
863K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib
|
|
SouthernAccent
|
6 |
2.1K |
4 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
6
|
2.1K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
SouthernAccent
|
20 |
8.0K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
20
|
8.0K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.7K |
1.1M |
19 |
22/10/23 |
22/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
19
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
SouthernAccent
|
30 |
9.6K |
3 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
30
|
9.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
SouthernAccent
|
30 |
9.6K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
30
|
9.6K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
SouthernAccent
|
2.0K |
619K |
5 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
619K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
SouthernAccent
|
677 |
321K |
7 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
677
|
321K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
SouthernAccent
|
2.0K |
619K |
1 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
619K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Commercial Scale Manufacturing of Efti for Clinical Trials
|
|
SouthernAccent
|
29 |
12K |
4 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
29
|
12K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Commercial Scale Manufacturing of Efti for Clinical Trials
|
|
SouthernAccent
|
29 |
12K |
9 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
29
|
12K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
SouthernAccent
|
2.0K |
619K |
4 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
2.0K
|
619K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
SouthernAccent
|
2.0K |
619K |
1 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
2.0K
|
619K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
SouthernAccent
|
10K |
4.6M |
1 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
10K
|
4.6M
|
1
|
|